Biocert International Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.50 M
as on 16-11-2024
- Company Age 10 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.30 M
as on 16-11-2024
- Satisfied Charges ₹ 1.10 Cr
as on 16-11-2024
- Revenue -3.96%
(FY 2023)
- Profit -3.86%
(FY 2023)
- Ebitda -2.58%
(FY 2023)
- Net Worth 109.77%
(FY 2023)
- Total Assets 85.14%
(FY 2023)
About Biocert International
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹0.30 M. The company has closed loans amounting to ₹1.10 Cr, as per Ministry of Corporate Affairs (MCA) records.
Dilip Dhaker and Vishal serve as directors at the Company.
- CIN/LLPIN
U01403MP2014PTC032540
- Company No.
032540
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Mar 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Biocert International Private Limited offer?
Biocert International Private Limited offers a wide range of products and services, including ISO & Quality Management Consultants, Certification Services, Quality Inspection Service, Inspection Service.
Who are the key members and board of directors at Biocert International?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dilip Dhaker  | Director | 21-Mar-2014 | Current |
| Vishal | Director | 13-Aug-2024 | Current |
Financial Performance of Biocert International.
Biocert International Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.96% decrease. The company also saw a slight decrease in profitability, with a 3.86% decrease in profit. The company's net worth Soared by an impressive increase of 109.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biocert International?
In 2022, Biocert International had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 14 Oct 2020 | ₹0.30 M | Open |
Others Creation Date: 08 Feb 2021 | ₹1.10 Cr | Satisfied |
How Many Employees Work at Biocert International?
Biocert International has a workforce of 1 employees as of Mar 26, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biocert International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biocert International's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
